📊 Score Breakdown
Offering Ability
90
Cash Runway
65
Float Risk
10
Warrant Exposure
30
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
54%
🔄 Reverse Split
65%
• 50-day avg $0.97 below $1 exchange minimum
• 10 months cash with weak price
📉 Score Deterioration
50%
• Score rose 46 points recently (worsening)
• Score in HIGH risk zone (65/100)
💰 Capital Raise
35%
• Under 12 months cash (10mo)
• Active shelf registration ($20M, 167% of market cap)
💹 Market Data
Market Cap$11.97M
Shares Outstanding15.43M
Float14.19M
Cash$7.70M
Debt$11.80M
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 56.9K shares
#1
Geode Capital Management, LLC
19.3K shares
#2
Vanguard Group Inc
15.2K shares
#3
Virtu Financial LLC
11.3K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest835.7K
Days to Cover1.0
% of Float5.9%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Dec 31, 2025
S-1/A
SHELF
May 08, 2026
S-1
SHELF
Apr 17, 2026
13F-HR
BENEFICIAL OWNERSHIP
Mar 31, 2026
13F-HR
BENEFICIAL OWNERSHIP
Mar 31, 2026
Full SEC filing analysis available with free account →
📰 Recent News
🔬 More Research for RIME
📊 RIME FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 RIME Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.